Literature DB >> 20528790

Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5.

M Cakir1, C Bruno, A Cansu, U Cobanoglu, E Erduran.   

Abstract

UNLABELLED: We described a Turkish girl with Chanarin-Dorfman syndrome who developed liver cirrhosis in the early infancy. She had all the clinical features of Chanarin-Dorfman syndrome such as ichthyosis, Jordan's anomaly, fatty liver disease and mild ectropion. The diagnosis was confirmed with a novel ABHD5 mutation. Liver steatosis or steatohepatitis with or without hepatomegaly is the predominant finding of Chanarin-Dorfman syndrome. Cirrhosis has been reported in patients with long-duration disease.
CONCLUSION: Local factors or dysfunction of local proteins such as mutations or polymorphisms in hepatic microsomal lipase and arylacetamide deacetylase may contribute the severity of liver involvement, and steatosis may progress to cirrhosis in the early infancy in Chanarin-Dorfman syndrome.
© 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Paediatrica.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528790     DOI: 10.1111/j.1651-2227.2010.01869.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

Review 1.  CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.

Authors:  Liqing Yu; Yi Li; Alison Grisé; Huan Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 2.  Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.

Authors:  Amanda L Brown; J Mark Brown
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-08-04       Impact factor: 4.698

Review 3.  Comparative gene identification-58/α/β hydrolase domain 5: more than just an adipose triglyceride lipase activator?

Authors:  Kathrin A Zierler; Rudolf Zechner; Guenter Haemmerle
Journal:  Curr Opin Lipidol       Date:  2014-04       Impact factor: 4.776

4.  Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*).

Authors:  Rita Quelhas da Costa; Francisco Laranjeira; Isaura Duarte Ribeiro; António Filipe Santos; Filipe Nery
Journal:  GE Port J Gastroenterol       Date:  2021-07-07

5.  A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia.

Authors:  Mugdha Joshi; Jacqueline Eagan; Nirav K Desai; Stephanie A Newton; Meghan C Towne; Nicholas S Marinakis; Kristyn M Esteves; Sarah De Ferranti; Michael J Bennett; Adam McIntyre; Alan H Beggs; Gerard T Berry; Pankaj B Agrawal
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

Review 6.  Recent insights into the structure and function of comparative gene identification-58.

Authors:  Monika Oberer; Andras Boeszoermenyi; Harald M Nagy; Rudolf Zechner
Journal:  Curr Opin Lipidol       Date:  2011-06       Impact factor: 4.776

7.  Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease.

Authors:  Franz Pw Radner; Susanne Grond; Guenter Haemmerle; Achim Lass; Rudolf Zechner
Journal:  Dermatoendocrinol       Date:  2011-04-01

8.  A rare cause of Fatty liver and elevated aminotransferase levels: chanarin-dorfman syndrome: a case report.

Authors:  Ozdal Ersoy; Canan Alkım; Mehmet Derya Onuk; Hüseyin Demirsoy; Dilek Argon
Journal:  Int J Hepatol       Date:  2011-01-20

9.  Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter.

Authors:  Sara Missaglia; Eugenia Ribeiro Valadares; Laura Moro; Eleonora Druve Tavares Faguntes; Raquel Quintão Roque; Bruno Giardina; Daniela Tavian
Journal:  BMC Med Genet       Date:  2014-03-14       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.